Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1992
10/26/1992WO1992019732A1 Closed sense and antisense oligonucleotides and uses thereof
10/26/1992CA2102229A1 Closed sense and antisense oligonucleotides and uses thereof
10/26/1992CA2067288A1 Sulfonamides and their medical use
10/26/1992CA2067070A1 Pharmaceutical compositions useful for gastroenterology
10/26/1992CA2066492A1 C-3 phosphine oxide substituted carbacephalosporins
10/25/1992CA2066960A1 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapy
10/25/1992CA2066938A1 N-imidazolyl derivatives of substituted indole
10/25/1992CA2066856A1 Substituted oxotremorine derivatives
10/25/1992CA2066826A1 Thienyl-nonatetraenoic acid derivatives
10/24/1992CA2066842A1 Corneal treatment agents
10/24/1992CA2066509A1 N-hydroxy-n-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas
10/24/1992CA2066508A1 N-hydroxy-n-(3-(2-(halophenylthio)phenyl) prop-2-enyl)-ureas as lipoxygenase inhibitors
10/24/1992CA2066499A1 Lipophilic macrolide useful as an immunosuppressant
10/24/1992CA2066494A1 Lipophilic macrolide useful as an immunosuppressant
10/23/1992WO1992018504A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND ANTI-INFLAMMATORY CONTAINING THE SAME
10/23/1992WO1992018483A1 Quinoline derivatives
10/23/1992WO1992018163A1 Medicine for intraocular operation
10/23/1992CA2108971A1 Quinoline derivatives
10/23/1992CA2085732A1 Pharmaceutical composition for use in intraocular surgery
10/23/1992CA2066468A1 Use of r(+)-3-amino-1-hydroxy-pyrrolidin-2-one for treating anxiety
10/22/1992DE4211812A1 New water-soluble 2-(2,6-di:oxo-3-piperidinyl)-1H-iso-indole-1-di:one deriv. - may be administered parenterally and have comparable activity to thalidomide itself
10/22/1992DE4112353A1 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung 1,3,4-tri-substituted piperidine derivatives, their preparation and use
10/22/1992DE4112303A1 Nitroglycerin, propellant gas-free spray prepn. - stored in container in which the steel parts are made of V4A series steels to inhibit nitroglycerin decomposition
10/21/1992EP0509974A1 Pyrrolo[2,3-b]pyridines having therapeutic activity and a process for the preparation thereof
10/21/1992EP0509913A1 Use of piribedil derivatives and analogs for the manufacture of medicaments for treatment of hyperreflexie or unstable bladders
10/21/1992EP0509906A1 Complexes of Polyadenylic acid with polyuridylic acid for the treatment of AIDS
10/21/1992EP0509845A1 (+) and (-) enantiomers of 5-aliphatic-6-(benzoxazinyl- or benzothiazinyl)-2,3,4,5-tetrahydropyridazin-3-ones
10/21/1992EP0509795A2 Carbamates of rapamycin
10/21/1992EP0509780A1 2-phenanthridonyl carbapenems
10/21/1992EP0509769A2 Heterocyclic amides having HLE inhibiting activity
10/21/1992EP0509762A1 Indole and dihydroquinoline potassium channel openers
10/21/1992EP0509761A1 Transdermal composition containing selegiline
10/21/1992EP0509756A1 2-Phenanthridonyl carbapenems having cationizeable substituents
10/21/1992EP0509753A1 Semi-synthetic immunosuppressive macrolides
10/21/1992EP0509752A2 Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist
10/21/1992EP0509656A1 Compositions of phytosterols and phytosterolins as immunmodulators
10/21/1992EP0509643A1 Anti-cancer compounds
10/21/1992EP0509598A1 Use of ibopamine for the manufacture of a pharmaceutical composition for the treatment of glaucomatous optic neuropathy
10/21/1992EP0509470A2 Therapeutical compositions having anti-HIV activity consisting of 2',3'-didesoxyadenosine and substances inhibiting adenosine deaminase
10/21/1992EP0509469A1 Synthetic compounds suitable for the therapy of infections caused by rhinoviruses
10/21/1992EP0509442A1 Use of neutral endopeptidase inhibitors in the treatment of nephrotoxicity
10/21/1992EP0509421A1 Hyperpigmentation of skin
10/21/1992EP0509402A1 Substituted 3-(Pyridinylamino)-indoles and benzo[b]thiophenes, a process for their preparation and their use as medicaments
10/21/1992EP0509401A1 Use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
10/21/1992EP0509400A1 1-(Pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles, intermediates and a process for their preparation, and their use as medicaments
10/21/1992EP0509398A1 Quinoxalines, process for their preparation and their use
10/21/1992EP0509359A1 Process for the preparation of pure enantiomers of substituted (quinolin-2-yl-methoxy)phenylacetic acids
10/21/1992EP0509354A2 Amino acid derivatives
10/21/1992EP0509335A1 Gastroresistant pharmaceutical formulations for oral administration containing bile acids
10/21/1992EP0509317A2 Use of droloxifene in the treatment of bone diseases
10/21/1992EP0509268A1 Use of clove oil for the treatment of benign prostate hyperplasia
10/21/1992EP0509259A1 The use of aminosteroids for the preparation of pharmaceutical compositions
10/21/1992EP0509180A1 Use of GABA-T inhibitors for the treatment of schizophrenia and phencyclidine intoxication
10/21/1992EP0509098A1 Ataractic
10/21/1992EP0509088A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
10/21/1992EP0509066A1 Use of alanine for the preparation of a pharmaceutical composition for protecting the heart against ischemia
10/21/1992EP0509036A1 Optically pure r(-) albuterol for treating asthma.
10/21/1992EP0509033A1 4,4'- 9h-fluoren-9-ylidenebis(methylene)]-bispyrimidine for treating neurological disorders
10/21/1992EP0509027A1 A process to correct and optimize the composition of a feed.
10/21/1992EP0509019A1 Treatment of human retroviral infections with 2',3'-dideoxyinosine
10/21/1992EP0509009A1 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent.
10/21/1992EP0509005A1 Diphenylsulphoximine muscarinic receptor antagonists
10/21/1992EP0508999A1 Pharmaceutically active normonyl compounds
10/21/1992EP0506845A4 Uncharged morpholino-based polymers having achiral intersubunit linkages
10/21/1992EP0500688A4 Method for inhibiting the growth of salmonella
10/21/1992EP0373213B1 Utilization of a folinic substance as platelet antiaggregating agent
10/21/1992CN1065490A Dna sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom
10/21/1992CN1065465A Polyethylene protein conjugates
10/21/1992CN1065462A Substituted 2',3'-dideoxy-5-trifluoromethylur idines, processes for their preparation and their use in medicaments
10/21/1992CN1065460A Nonsaditive antihistaminics derived from benzimidazoles
10/21/1992CN1065459A Piperidine derivatives and process for them and use in therapy
10/21/1992CN1065458A Polytehoxylated vitamin e and a method for preparation thereof
10/21/1992CN1065455A Piperiding derivatives
10/21/1992CN1018733B N-phenylpyrazole derivatives
10/20/1992WO1992018543A1 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
10/20/1992US5157151 Antiinflammatory agents
10/20/1992US5157140 Esters of myo-inositol phosphate
10/20/1992US5157135 Treatment of bone disorders, renal diseases
10/20/1992US5157129 Enantiospecific synthesis of s-(+)-5,6-dihydro-4-(r-amino)-4h-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide
10/20/1992US5157128 Certain optically active substituted α,α-dialkyl-pyrrolidine-3-methamines useful as intermediates
10/20/1992US5157117 (6,7)-substituted-8-alkoxy-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid-03,04) bis (acyloxy-0) borate and the salt thereof, and the preparing method of the same
10/20/1992US5157116 Antidiabetic agents
10/20/1992US5157114 2',3'-dideoxy-3'-fluoro-5-ethyngluridine
10/20/1992US5157104 Antitumor, anticarcinogenic agents
10/20/1992US5157052 Method for inhibiting ige production
10/20/1992US5157049 Method of treating cancers sensitive to treatment with water soluble derivatives of taxol
10/20/1992US5157046 Method of treating epithelial disorders
10/20/1992US5157044 Analogs of carbonic anhydrase inhibitors and their use as topical IOP inhibitors
10/20/1992US5157042 3-oxa-5-fluoro-carbacyclins, their preparation and use as medicinal agents
10/20/1992US5157041 Viricides
10/20/1992US5157040 Substituted quinolines as angiotensin ii antagonists
10/20/1992US5157039 2-quinolinyl methoxy compounds, medical uses and intermediates therefor
10/20/1992US5157038 Antidepressants; tranquilizers; treatment of schizophrenia and epilepsy; antilepmic agents
10/20/1992US5157035 Anti-virally active pyridazinamines
10/20/1992US5157034 Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
10/20/1992US5157030 Adding lecithin polysorbate, glycerol monostearate, or polyether surfactant
10/20/1992US5157027 Bisphosphonate squalene synthetase inhibitors and method
10/20/1992US5157025 Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
10/20/1992US5157024 Method of enhancing the activity of phagocytes including macrophages, modulating the cellular or humoral immune response, and reducing the adverse effects of stress in warm blooded animals
10/20/1992US5157022 Method for reducing blood cholesterol using arginine
1 ... 7239 7240 7241 7242 7243 7244 7245 7246 7247 7248 7249 7250 7251 7252 7253 7254 7255 7256 7257 7258 7259 ... 7860